Journal of Pharmacy and Pharmaceutical Research Open Access

  • Journal h-index: 5
  • Journal CiteScore: 0.94
  • Journal Impact Factor: 0.52
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Volume 5, Issue 3 (2021)

Short Article

Knowledge, attitude, and practice on human papilloma virus vaccination: A cross sectional study among university students

  • Cervical cancer is the third most common cancer among women worldwide. Human Papillomavirus (HPV) is the main cause for cervical cancer as well as vulvar, vaginal, penile, anal and also oropharyngeal cancer. The burden of HPV-associated disease is still high across numerous countries regardless of the technological advancement in conveying information pertaining to the disease. Lack of awareness on HPV as well as misunderstandings on the risks associated with HPV vaccination can expose females to the disease and complications that arise from HPV.

Short Article

Scientific Evidence Supporting Benefits of Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015â??2017

  • US Food and Drug Administration (FDA) exercises flexibility in the requirement that new drugs provide substantial evidence of benefit under the Food, Drug and Cosmetic Act. Provisions in law and policy provide numerous exceptions to the historical scientific standard of 2 or more controlled clinical trials demonstrating statistically significant evidence of benefit.